Madsen K - Search Results

1

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.

Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ. Deacon CF, et al. Among authors: madsen k. Diabetologia. 1998 Mar;41(3):271-8. doi: 10.1007/s001250050903. Diabetologia. 1998. PMID: 9541166

2

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.

Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thøgersen H, Wilken M, Agersø H. Knudsen LB, et al. Among authors: madsen k. J Med Chem. 2000 May 4;43(9):1664-9. doi: 10.1021/jm9909645. J Med Chem. 2000. PMID: 10794683

3

Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.

Runge S, Wulff BS, Madsen K, Bräuner-Osborne H, Knudsen LB. Runge S, et al. Among authors: madsen k. Br J Pharmacol. 2003 Mar;138(5):787-94. doi: 10.1038/sj.bjp.0705120. Br J Pharmacol. 2003. PMID: 12642379 Free PMC article.

4

The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs.

Simonsen L, Holst JJ, Madsen K, Deacon CF. Simonsen L, et al. Among authors: madsen k. Regul Pept. 2013 Feb 10;181:17-21. doi: 10.1016/j.regpep.2012.12.012. Epub 2013 Jan 11. Regul Pept. 2013. PMID: 23318502

5

Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals.

Haahr ME, Hansen DL, Fisher PM, Svarer C, Stenbæk DS, Madsen K, Madsen J, Holst JJ, Baaré WF, Hojgaard L, Almdal T, Knudsen GM. Haahr ME, et al. Among authors: madsen k, madsen j. J Neurosci. 2015 Apr 8;35(14):5884-9. doi: 10.1523/JNEUROSCI.3348-14.2015. J Neurosci. 2015. PMID: 25855196 Free PMC article.

6

Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study.

Haahr ME, Fisher PM, Jensen CG, Frokjaer VG, Mahon BM, Madsen K, Baaré WF, Lehel S, Norremolle A, Rabiner EA, Knudsen GM. Haahr ME, et al. Among authors: madsen k. Mol Psychiatry. 2014 Apr;19(4):427-32. doi: 10.1038/mp.2013.147. Epub 2013 Nov 5. Mol Psychiatry. 2014. PMID: 24189342 Clinical Trial.

7

Important role of C-terminal peptide bonds for endothelin receptor binding and activity.

Olsen UB, Weis JU, Suzdak P, Lundt BF, Madsen K, Thøgersen H, Johansen NL. Olsen UB, et al. Among authors: madsen k. Pharmacol Toxicol. 1993 Jul;73(1):60-2. doi: 10.1111/j.1600-0773.1993.tb01960.x. Pharmacol Toxicol. 1993. PMID: 8234195 No abstract available.

8

Ipamorelin, the first selective growth hormone secretagogue.

Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Raun K, et al. Among authors: madsen k. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. Eur J Endocrinol. 1998. PMID: 9849822

9

Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.

Ingwersen SH, Jørgensen PN, Eiskjaer H, Johansen NL, Madsen K, Faarup P. Ingwersen SH, et al. Among authors: madsen k. J Immunol Methods. 1992 May 18;149(2):237-46. doi: 10.1016/0022-1759(92)90255-r. J Immunol Methods. 1992. PMID: 1534341

10

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thogersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH. Ankersen M, et al. Among authors: madsen k. J Med Chem. 1998 Sep 10;41(19):3699-704. doi: 10.1021/jm9801962. J Med Chem. 1998. PMID: 9733495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,218 results

Search Page

Filters